Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 08, 2020 07:00 ET | Source: Adicet Bio, Inc.

Adicet Bio to Participate in Fireside Chat at JMP Securities Hematology Summit

MENLO PARK, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell therapies for...
December 01, 2020 07:00 ET | Source: Adicet Bio, Inc.

Adicet Announces Appointment of Dr. Bastiano Sanna to its Board of Directors

MENLO PARK, Calif. and BOSTON, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell...
November 06, 2020 07:00 ET | Source: Adicet Bio, Inc.

Adicet Bio to Participate in Upcoming Investor Conferences

MENLO PARK, Calif. and BOSTON, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell...
November 05, 2020 16:10 ET | Source: Adicet Bio, Inc.

Adicet Reports Third Quarter 2020 Financial Results and Provides Business Update

MENLO PARK, Calif. and BOSTON, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell...
October 26, 2020 16:10 ET | Source: Adicet Bio, Inc.

Adicet Appoints Don Healey, Ph.D., as Chief Technology Officer

MENLO PARK, Calif. and BOSTON, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell...
October 22, 2020 07:00 ET | Source: Adicet Bio, Inc.

Adicet Announces FDA Clearance of IND Application for First-in-Class Allogeneic CAR Gamma-Delta T Cell Therapy

MENLO PARK, Calif. and BOSTON, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for...
October 01, 2020 16:10 ET | Source: Adicet Bio, Inc.

Adicet Bio to Present at the Jefferies Cell Therapy Summit

MENLO PARK, Calif. and BOSTON, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for...
September 22, 2020 22:42 ET | Source: Adicet Bio, Inc.

Adicet Bio, Inc. Determines Not to Proceed with Public Offering of Common Stock

MENLO PARK, Calif. and BOSTON, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for...
September 21, 2020 07:00 ET | Source: Adicet Bio, Inc.

Adicet Bio, Inc. Announces Proposed Public Offering of Common Stock

MENLO PARK, Calif. and BOSTON, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell...
September 18, 2020 16:10 ET | Source: Adicet Bio, Inc.

Adicet Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

MENLO PARK, Calif. and BOSTON, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right